Oxytocin
FDA ApprovedAlso known as: Pitocin, Syntocinon, OXT
Educational Content Only
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The FDA has not evaluated many of the peptides discussed here. Always consult a licensed healthcare provider before making any health decisions.
Oxytocin is a nine-amino acid neuropeptide hormone produced in the hypothalamus and released by the posterior pituitary, studied extensively for its roles in social bonding, trust, maternal behavior, uterine contraction, and lactation. It is FDA-approved for obstetric indications and has been extensively studied in clinical contexts including autism spectrum disorder and social anxiety.
The following areas have been examined in research contexts. This does not constitute medical advice or imply proven efficacy in humans.
- Sexual Function
- Cognitive Enhancement
Oxytocin acts through G-protein coupled oxytocin receptors distributed throughout the brain, uterus, and mammary glands. Research implicates oxytocinergic signaling in modulation of dopaminergic reward circuits, HPA axis stress responses, and prosocial behavior.
FDA-approved for obstetric use (Pitocin). Intranasal formulations are used off-label and in research settings. May cause water retention, uterine hyperstimulation in obstetric doses. Research use in social and psychiatric contexts is ongoing.
Want to learn more?
Ask Research Chat about OxytocinHalf-Life
~1-6 minutes (plasma); longer central effects
Administration
intravenous (obstetric), intranasal (research), subcutaneous injection
Legal Status (US)
FDA-approved prescription medication for obstetric use. Intranasal research formulations are compounded or research-grade.
199 indexed research passages
Related Peptides
P21 is a short synthetic peptide derived from humanin with modifications intended to enhance potency and stability. Research has examined its potential roles in neuroprotection, cognitive function, and cellular survival signaling, particularly in the context of Alzheimer's disease models and age-related cognitive decline.
Tropisetron is a 5-HT3 receptor antagonist and alpha7 nicotinic acetylcholine receptor agonist approved in various countries for chemotherapy-induced nausea. Research has also examined its potential roles in pain management, fibromyalgia, and cognitive enhancement through its dual receptor pharmacology.
Lemairamin is a plant-derived alkaloid (isolated as WGX-50 from Evodia lepta) studied in the context of neuroprotection and neurological aging. Research in animal models has examined its potential to protect neurons from amyloid-beta toxicity and oxidative stress, with interest in Alzheimer's disease research.
9-ME-BC is a synthetic β-carboline alkaloid with structural similarity to naturally occurring harman compounds. Research in animal models has examined its potential neuroprotective, dopaminergic, and pro-cognitive properties, with particular interest in its ability to promote neurogenesis and dendritic growth in dopaminergic neurons.